 鲜花( 85)  鸡蛋( 2)
|

楼主 |
发表于 2015-2-28 21:48
|
显示全部楼层
Stock soars after Cold-fX wins crucial approval
H8 D8 m% ]: T4 v- Z# e / S3 `+ l: X% t* `1 E
EDMONTON - CV Technologies Inc. shares rose nearly 60 per cent Thursday after Health Canada approved the claims at the core of the company's marketing of its cold and flu drug Cold-fX.+ z1 `% s5 v# n# r- Y- p! A* ?
9 |; _( `* j) E8 E& Q, g. i
BY THE EDMONTON JOURNAL FEBRUARY 16, 2007 I. S4 a1 c3 G* ^, A7 a `
. m. g7 `9 P9 a( {
! w, {8 X7 K; g% cEDMONTON - CV Technologies Inc. SHARES rose nearly 60 per cent Thursday after Health Canada approved the claims at the core of the company's marketing of its cold and flu drug Cold-fX.. x; b/ Z+ k4 Z9 |' K$ m
. e. ]% }6 m+ K
The agency said CV Technologies can continue to market Cold-fX as helping "to reduce the frequency, severity and duration of cold and flu symptoms by boosting the IMMUNE SYSTEM."
* v$ T; T9 H) F" k' @8 N8 C; v, x& U: g3 s. T! W3 `8 [
The APPROVAL follows a review of seven clinical trials and more than 10 years of research about the product.
: u2 \4 m; Z7 M9 n" a% ]) A
; k0 U8 i, R7 ^, ]9 vIt should create even more confidence among consumers and medical professionals that the product works, CEO Jacqueline Shan said Thursday.* |: t& U k- a- ?* _- h8 q
3 v0 J+ j' J' D
It certainly instilled confidence in the market, as shares closed at $2.90 on THE TORONTO STOCK EXCHANGE, up $1.08 on a volume of 4.6 million.
' v6 a) x! J9 j6 L% j$ p# b+ ~. a/ B4 d
"As a scientist, it's one of the highlights of my CAREER," Shan said.# u& R+ f. j. E6 H
. i& m% a4 X1 X: q
"This approval is a breakthrough in realizing our vision of being a global leader in developing products for disease prevention."
# H$ e2 j) F2 ]( h$ I) k+ E+ K1 p5 n- z/ ?$ j4 `
It's Cold-fX's strongest medical recognition to date, said Shan. It means the company can advertise the HEALTH BENEFITS more effectively to consumers and health professionals, she said.: X% e" \! c# S6 w
. i+ {/ M, R* m( k+ @Ginseng-based Cold-fX is already the top-selling cold and flu treatment in Canada, but Shan said there is plenty of room for more growth.
. W8 ^* l8 x( _5 m4 o0 S0 s: c) S5 \
, w" W' w( x4 BThe approval will also help raise the product's PROFILE in the lucrative U.S. market, which Cold-fX entered in October. The move came with a new marketing push, using former Oilers superstar Mark Messier as its spokesman.7 G) _- F0 j5 ?7 h
! n2 |3 _! }1 q! n; M
$ b8 D5 @. l4 @" |5 P. h5 Bhttp://www.canada.com/story.html ... 9-be80-f40f1426f662 |
|